Joseph Truitt

2018

In 2018, Joseph Truitt earned a total compensation of $3.3M as Director, President and Chief Executive Officer at Achillion Pharmaceuticals, a 209% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$255,640
Option Awards$2,502,220
Salary$509,400
Other$8,731
Total$3,275,991

Truitt received $2.5M in option awards, accounting for 76% of the total pay in 2018.

Truitt also received $255.6K in non-equity incentive plan, $509.4K in salary and $8.7K in other compensation.

Rankings

In 2018, Joseph Truitt's compensation ranked 3,511th out of 14,244 executives tracked by ExecPay. In other words, Truitt earned more than 75.4% of executives.

ClassificationRankingPercentile
All
3,511
out of 14,244
75th
Division
Manufacturing
1,297
out of 5,759
78th
Major group
Chemicals And Allied Products
455
out of 2,122
79th
Industry group
Drugs
375
out of 1,811
79th
Industry
Pharmaceutical Preparations
288
out of 1,385
79th
Source: SEC filing on April 15, 2019.

Truitt's colleagues

We found five more compensation records of executives who worked with Joseph Truitt at Achillion Pharmaceuticals in 2018.

2018

Milind Deshpande

Achillion Pharmaceuticals

Chief Executive Officer

2018

Steven Zelenkofske

Achillion Pharmaceuticals

Chief Medical Officer

2018

Paul Firuta

Achillion Pharmaceuticals

Chief Operating Officer

2018

Mary Fenton

Achillion Pharmaceuticals

Chief Financial Officer

2018

Anthony Gibney

Achillion Pharmaceuticals

Executive Vice President and Chief Business Officer

News

In-depth

You may also like